Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
High Performance Technologies, Inc. (HPTi) was a professional services firm specializing in high-performance computing, systems engineering, and software development for federal agencies. Within the healthcare and life sciences sector, HPTi was a prominent contractor for the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA), providing critical bioinformatics support and health informatics solutions. The company played a key role in supporting the National Center for Biotechnology Information (NCBI), including the management of the Sequence Read Archive (SRA), and contributed to the Cancer Biomedical Informatics Grid (caBIG). HPTi was acquired by Dynamics Research Corporation (DRC) in 2011 for approximately $143 million, and its capabilities were later integrated into larger defense and technology firms following subsequent acquisitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HPTi.